Prostate cancer vaccine (Pepscan Therapeutics)

N/A

Report date: 2022/11/25 18:07:15

Base Information

Drug NameProstate cancer vaccine (Pepscan Therapeutics)
Drug Alias NamePEP-223/CoVaccine HT前列腺癌疫苗-Pepscan TherapeuticsCoVaccine HT/PEP-223
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionGonadotropin-releasing hormone antagonists
TargetsGonadotropin-releasing hormone
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPepscan Systems
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPepscan Therapeutics Bv
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A